Neural‐tube defects and vitamins: the need for a randomized clinical trial
- 1 June 1984
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 91 (6), 516-523
- https://doi.org/10.1111/j.1471-0528.1984.tb04796.x
Abstract
It has been suggested that taking extra vitamins around the time of conception may reduce the risk of fetal neural‐tube defects. We have examined the evidence for this and conclude that there is considerable doubt about the efficacy of such a regimen. Also, it cannot be assumed that the taking of extra vitamins has no adverse medical effects. We give reasons for our view that a large randomized clinical trial is ethical and the only satisfactory way of resolving the matter. The Medical Research Council is currently conducting such a study in centres in Britain and abroad, involving women who have already had a pregnancy with a fetal neural‐tube defect. The design of the Medical Research Council study is described briefly.Keywords
This publication has 27 references indexed in Scilit:
- Recurrence risk of neural tube defects following a miscarriagePrenatal Diagnosis, 1983
- VITAMIN SUPPLEMENTATION FOR PREVENTION OF NEURAL TUBE DEFECT RECURRENCESThe Lancet, 1983
- VITAMIN SUPPLEMENTATION AND NEURAL TUBE DEFECTSThe Lancet, 1982
- Apparent prevention of neural tube defects by periconceptional vitamin supplementation.Archives of Disease in Childhood, 1981
- Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling.BMJ, 1980
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectNew England Journal of Medicine, 1980
- RECURRENCE RISK OF NEURAL TUBE DEFECTSThe Lancet, 1980
- VITAMIN B12 AND ANENCEPHALYThe Lancet, 1980
- Neural tube defects in curly-tail mice. II. Effect of maternal administration of vitamin AProceedings of the Royal Society of London. B. Biological Sciences, 1979
- Clofibrate in coronary heart disease. Effect on morbidity and mortalityPublished by American Medical Association (AMA) ,1972